Sally Susman’s Post

🎉 Proud Moment Alert! 🎉 Today, we celebrate the 175th Anniversary of Pfizer, a legacy of breakthroughs, innovation, and unwavering commitment to healthcare. Reflecting on my journey since joining this incredible team in 2015, I'm overwhelmed with gratitude. Pfizer's story is a global movement towards a healthier world, not just about a company. Throughout its rich history, Pfizer has led medical innovation, from pioneering the first mass-produced antibiotic to combating global health crises. As we step into this significant year, the collaborative spirit, resilience, and dedication that define Pfizer are evident. It's a privilege to be part of a community making history every day. To all colleagues, past and present, your contributions have shaped Pfizer into what it is today. Together, we've witnessed and made history. Here's to celebrating 175 years of innovation, diligence, and compassion. Looking to the future, I anticipate the new chapters we are yet to write. May we lead with purpose, drive forward our mission, and touch more lives with our work. #Pfizer175 #Innovation #Healthcare #AnniversaryCelebration #MakingHistory #PfizerProud

How do you use purpose to unlock potential and engage employees when time is the most precious commodity in healthcare? We helped AstraZeneca save 2 million hours of employee time so they can focus on what really matters – helping patients around the world. Our simplification programme led to hours that were repurposed on extra clinical trials that improved the lives of over 4 million patients. Furthermore, employees are now more engaged and with the extra time can confidently deliver on AstraZeneca's purpose: to push the boundaries of science to deliver life-changing medicines. Find out more about the work here: https://hubs.li/Q02bCBJn0 #healthcare #employeeEngagement #productivity

🌈 𝑩𝒓𝒆𝒂𝒌𝒕𝒉𝒓𝒐𝒖𝒈𝒉𝒔 𝒊𝒏 𝑪𝒉𝒓𝒐𝒏𝒊𝒄 𝑫𝒆𝒑𝒓𝒆𝒔𝒔𝒊𝒗𝒆 𝑷𝒆𝒓𝒔𝒐𝒏𝒂𝒍𝒊𝒕𝒚 𝑫𝒊𝒔𝒐𝒓𝒅𝒆𝒓 𝑻𝒓𝒆𝒂𝒕𝒎𝒆𝒏𝒕 𝑰𝒍𝒍𝒖𝒎𝒊𝒏𝒂𝒕𝒆 𝒂 𝑷𝒂𝒕𝒉 𝒕𝒐 𝑹𝒆𝒄𝒐𝒗𝒆𝒓𝒚! Exciting #progress is underway in the treatment of Chronic #Depressive Personality #disorder (CDPD), offering renewed hope for #patients globally. Innovative therapies, holistic approaches, and precision interventions are reshaping the landscape. Global collaboration is uniting efforts, and #patientcare -centric, tailored care is empowering resilience. With breakthroughs in research and urgent progress alerts, there's a transformative shift towards a brighter future for those facing #CDPD. 🌐💪🌟 𝑭𝒐𝒓 𝑴𝒐𝒓𝒆 𝑰𝒏𝒇𝒐: https://bit.ly/4bxGyUq Key Players: Eli Lilly and Company Forest Laboratories (now Allergan) GlaxoSmithKline Consumer Healthcare, L.P. Merck Sharp & Dohme Federal Credit Union Pfizer Allergan. Novartis #CDPD #MentalHealthAdvancements

When we embrace equity, we all benefit. Everyone in healthcare touching the lives of patients and their loved ones, one way or another, must collectively commit to equity. In order for all of us to reimagine medicine together, for everyone in need and at scale. I’m looking forward to speaking with Kana Hutton at this week’s Reuters Events: Pharma USA on why it is important we embed equity in healthcare, from research to commercialization. And why collaboration across the healthcare ecosystem is the only way forward. #REpharmaUSA #healthequity #reimaginemedicine

Patient centricity means creating medicines with - not for people living with chronic diseases and their family caregivers.

It’s time. It's time to work together to earn back trust in healthcare. It’s time to build a more equitable healthcare system to ensure no one is left behind. It's time to move from conversation to action.   Members of our #AMillionConversations Advisory Group and Sanofi’s own Brian Foard discussed how to build trust in healthcare and if you didn't get chance to see the webinar live, you can watch the replay here: Healthcare Leaders Discuss Equity and Trust (sanofi.com) My key takeaway from the event? It really will take a village with deep and broad collaboration, but with greater inclusion, transparency and accountability, we can begin to earn back trust in healthcare from under-represented communities. #Amillionconversations

The opportunity to build frameworks that will accelerate access is in reach. Join this exclusive Reuters Events webinar on December 6 to hear from Novartis, AZ, Sanofi and Merck share their business-critical learnings: https://bit.ly/3QGu4Ab This discussion will also cover: • Tailor your products value proposition by having early conversations with committees, advocacy groups and ad boards. • Craft a robust evidence plan that will expedite product launch enabling a competitive edge in the market. • Harness patient-focused real world data that will strengthen payer value and accelerate access to medication. • More than drugmakers: Open new channels of business by creating new concepts of value, such as indicating health equity as a criteria. Sign-up here for free live and on-demand access: https://bit.ly/3QGu4Ab Don’t miss out! #marketaccess #rwe #rwd

The opportunity to build frameworks that will accelerate access is in reach. Join this exclusive Reuters Events webinar on December 6 to hear from Novartis, AZ, Sanofi and Merck share their business-critical learnings: https://bit.ly/3QGu4Ab This discussion will also cover: • Tailor your products value proposition by having early conversations with committees, advocacy groups and ad boards. • Craft a robust evidence plan that will expedite product launch enabling a competitive edge in the market. • Harness patient-focused real world data that will strengthen payer value and accelerate access to medication. • More than drugmakers: Open new channels of business by creating new concepts of value, such as indicating health equity as a criteria. Sign-up here for free live and on-demand access: https://bit.ly/3QGu4Ab Don’t miss out! #marketaccess #rwe #rwd